Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.
Samaranayake GJ, Troccoli CI, Huynh M, Lyles RDZ, Kage K, Win A, Lakshmanan V, Kwon D, Ban Y, Chen SX, Zarco ER, Jorda M, Burnstein KL, Rai P
Nat Commun. 2017 Oct 31;8(1):1204. doi: 10.1038/s41467-017-01269-x. PubMed
Samaranayake GJ, Troccoli CI, Huynh M, Lyles RDZ, Kage K, Win A, Lakshmanan V, Kwon D, Ban Y, Chen SX, Zarco ER, Jorda M, Burnstein KL, Rai P
Nat Commun. 2017 Oct 31;8(1):1204. doi: 10.1038/s41467-017-01269-x. PubMed
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 110919 | pblic-neo TRX1 | To overexpress Thioredoxin-1 |
| 110920 | plko-tet-on-puromycin-shTRX1-259 | To knockdown Thioredoxin-1 following doxycycline addition |